Skip to main content

Table 2 Estimated R&D cost of a new drug FDA (US$ millions).

From: Establishing a reasonable price for an orphan drug

 

Orphan drugs

Non-orphan drugs

% of orphans to non-orphans

All indications

501.2

2140.8

23.4

Oncology

511.6

2341.5

21.8

  1. Estimates have been calculated using data from 2015 novel drug approvals of FDA; Estimates for all indications include oncology products
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us